ID   SMG1_HUMAN              Reviewed;        3661 AA.
AC   Q96Q15; O43305; Q13284; Q8NFX2; Q96QV0; Q96RW3;
DT   04-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 3.
DT   12-OCT-2022, entry version 181.
DE   RecName: Full=Serine/threonine-protein kinase SMG1;
DE            Short=SMG-1;
DE            Short=hSMG-1;
DE            EC=2.7.11.1;
DE   AltName: Full=Lambda/iota protein kinase C-interacting protein {ECO:0000303|PubMed:8524286};
DE            Short=Lambda-interacting protein {ECO:0000303|PubMed:8524286};
DE   AltName: Full=Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1 {ECO:0000312|HGNC:HGNC:30045};
GN   Name=SMG1 {ECO:0000312|HGNC:HGNC:30045};
GN   Synonyms=ATX {ECO:0000312|HGNC:HGNC:30045}, KIAA0421
GN   {ECO:0000312|HGNC:HGNC:30045}, LIP {ECO:0000312|HGNC:HGNC:30045};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=9566925; DOI=10.1128/mcb.18.5.3069;
RA   Sanchez P., De Carcer G., Sandoval I.V., Moscat J., Diaz-Meco M.T.;
RT   "Localization of atypical protein kinase C isoforms into lysosome-targeted
RT   endosomes through interaction with p62.";
RL   Mol. Cell. Biol. 18:3069-3080(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, PHOSPHORYLATION OF RENT1,
RP   ALTERNATIVE SPLICING, ACTIVITY REGULATION, PHOSPHORYLATION, INTERACTION
RP   WITH RENT1; UPF2 AND UPF3, AND MUTAGENESIS OF ASP-2335.
RX   PubMed=11544179; DOI=10.1101/gad.913001;
RA   Yamashita A., Ohnishi T., Kashima I., Taya Y., Ohno S.;
RT   "Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase,
RT   associates with components of the mRNA surveillance complex and is involved
RT   in the regulation of nonsense-mediated mRNA decay.";
RL   Genes Dev. 15:2215-2228(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, PHOSPHORYLATION OF RENT1,
RP   COFACTOR, ACTIVITY REGULATION, AND MUTAGENESIS OF ASP-2335.
RX   PubMed=11331269; DOI=10.1074/jbc.c100144200;
RA   Denning G., Jamieson L., Maquat L.E., Thompson E.A., Fields A.P.;
RT   "Cloning of a novel phosphatidylinositol kinase-related kinase:
RT   characterization of the human SMG-1 RNA surveillance protein.";
RL   J. Biol. Chem. 276:22709-22714(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, PHOSPHORYLATION OF TP53,
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, ACTIVITY REGULATION, MUTAGENESIS
RP   OF ASP-2335, AND VARIANTS CYS-144 AND LYS-612.
RX   PubMed=15175154; DOI=10.1016/j.molcel.2004.05.005;
RA   Brumbaugh K.M., Otterness D.M., Geisen C., Oliveira V., Brognard J., Li X.,
RA   Lejeune F., Tibbetts R.S., Maquat L.E., Abraham R.T.;
RT   "The mRNA surveillance protein hSMG-1 functions in genotoxic stress
RT   response pathways in mammalian cells.";
RL   Mol. Cell 14:585-598(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1674-3661.
RC   TISSUE=Brain;
RX   PubMed=9455477; DOI=10.1093/dnares/4.5.307;
RA   Ishikawa K., Nagase T., Nakajima D., Seki N., Ohira M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VIII. 78
RT   new cDNA clones from brain which code for large proteins in vitro.";
RL   DNA Res. 4:307-313(1997).
RN   [7]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2878-3661, TISSUE SPECIFICITY, AND
RP   INTERACTION WITH PRKCI.
RX   PubMed=8524286; DOI=10.1128/mcb.16.1.105;
RA   Diaz-Meco M.T., Municio M.M., Sanchez P., Lozano J., Moscat J.;
RT   "Lambda-interacting protein, a novel protein that specifically interacts
RT   with the zinc finger domain of the atypical protein kinase C isotype
RT   lambda/iota and stimulates its kinase activity in vitro and in vivo.";
RL   Mol. Cell. Biol. 16:105-114(1996).
RN   [9]
RP   DUPLICATION.
RX   PubMed=11948212; DOI=10.1093/jhered/92.6.462;
RA   Eichler E.E., Johnson M.E., Alkan C., Tuzun E., Sahinalp C., Misceo D.,
RA   Archidiacono N., Rocchi M.;
RT   "Divergent origins and concerted expansion of two segmental duplications on
RT   chromosome 16.";
RL   J. Hered. 92:462-468(2001).
RN   [10]
RP   INTERACTION WITH SMG5.
RX   PubMed=14636577; DOI=10.1016/s1097-2765(03)00443-x;
RA   Ohnishi T., Yamashita A., Kashima I., Schell T., Anders K.R., Grimson A.,
RA   Hachiya T., Hentze M.W., Anderson P., Ohno S.;
RT   "Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes
RT   containing hSMG-5 and hSMG-7.";
RL   Mol. Cell 12:1187-1200(2003).
RN   [11]
RP   INTERACTION WITH RENT1; UPF2; EST1A AND UPF3B.
RX   PubMed=12554878; DOI=10.1261/rna.2137903;
RA   Chiu S.-Y., Serin G., Ohara O., Maquat L.E.;
RT   "Characterization of human Smg5/7a: a protein with similarities to
RT   Caenorhabditis elegans SMG5 and SMG7 that functions in the
RT   dephosphorylation of Upf1.";
RL   RNA 9:77-87(2003).
RN   [12]
RP   FUNCTION, INTERACTION WITH UPF2, AND IDENTIFICATION IN THE SURF COMPLEX.
RX   PubMed=16452507; DOI=10.1101/gad.1389006;
RA   Kashima I., Yamashita A., Izumi N., Kataoka N., Morishita R., Hoshino S.,
RA   Ohno M., Dreyfuss G., Ohno S.;
RT   "Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon
RT   junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA
RT   decay.";
RL   Genes Dev. 20:355-367(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3550 AND SER-3556, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3570, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   CATALYTIC ACTIVITY, AND IDENTIFICATION IN THE SMG1C COMPLEX.
RX   PubMed=19417104; DOI=10.1101/gad.1767209;
RA   Yamashita A., Izumi N., Kashima I., Ohnishi T., Saari B., Katsuhata Y.,
RA   Muramatsu R., Morita T., Iwamatsu A., Hachiya T., Kurata R., Hirano H.,
RA   Anderson P., Ohno S.;
RT   "SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate
RT   remodeling of the mRNA surveillance complex during nonsense-mediated mRNA
RT   decay.";
RL   Genes Dev. 23:1091-1105(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-173, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   INTERACTION WITH TELO2 AND TTI1.
RX   PubMed=20427287; DOI=10.1074/jbc.m110.121699;
RA   Kaizuka T., Hara T., Oshiro N., Kikkawa U., Yonezawa K., Takehana K.,
RA   Iemura S., Natsume T., Mizushima N.;
RT   "Tti1 and Tel2 are critical factors in mammalian target of rapamycin
RT   complex assembly.";
RL   J. Biol. Chem. 285:20109-20116(2010).
RN   [21]
RP   INTERACTION WITH TTI1.
RX   PubMed=20810650; DOI=10.1101/gad.1934210;
RA   Hurov K.E., Cotta-Ramusino C., Elledge S.J.;
RT   "A genetic screen identifies the Triple T complex required for DNA damage
RT   signaling and ATM and ATR stability.";
RL   Genes Dev. 24:1939-1950(2010).
RN   [22]
RP   INTERACTION WITH RUVBL1 AND RUVBL2.
RX   PubMed=20371770; DOI=10.1126/scisignal.2000468;
RA   Izumi N., Yamashita A., Iwamatsu A., Kurata R., Nakamura H., Saari B.,
RA   Hirano H., Anderson P., Ohno S.;
RT   "AAA+ proteins RUVBL1 and RUVBL2 coordinate PIKK activity and function in
RT   nonsense-mediated mRNA decay.";
RL   Sci. Signal. 3:RA27-RA27(2010).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3573, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   INTERACTION WITH SMG8 AND SMG9, AND ELECTRON MICROSCOPY OF THE SMG1C
RP   COMPLEX.
RX   PubMed=21245168; DOI=10.1101/gad.606911;
RA   Arias-Palomo E., Yamashita A., Fernandez I.S., Nunez-Ramirez R., Bamba Y.,
RA   Izumi N., Ohno S., Llorca O.;
RT   "The nonsense-mediated mRNA decay SMG-1 kinase is regulated by large-scale
RT   conformational changes controlled by SMG-8.";
RL   Genes Dev. 25:153-164(2011).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3550; SER-3556; SER-3570 AND
RP   THR-3573, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [28]
RP   INTERACTION WITH DHX34.
RX   PubMed=25220460; DOI=10.1016/j.celrep.2014.08.020;
RA   Hug N., Caceres J.F.;
RT   "The RNA helicase DHX34 activates NMD by promoting a transition from the
RT   surveillance to the decay-inducing complex.";
RL   Cell Rep. 8:1845-1856(2014).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3573, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   IDENTIFICATION IN A COMPLEX WITH DHX34 AND UPF1, AND INTERACTION WITH DHX34
RP   AND UPF1.
RX   PubMed=26841701; DOI=10.1038/ncomms10585;
RA   Melero R., Hug N., Lopez-Perrote A., Yamashita A., Caceres J.F., Llorca O.;
RT   "The RNA helicase DHX34 functions as a scaffold for SMG1-mediated UPF1
RT   phosphorylation.";
RL   Nat. Commun. 7:10585-10585(2016).
RN   [31]
RP   INTERACTION WITH RUVBL1; RUVBL2; SMG8 AND SMG9.
RX   PubMed=33205750; DOI=10.7554/elife.63042;
RA   Lopez-Perrote A., Hug N., Gonzalez-Corpas A., Rodriguez C.F., Serna M.,
RA   Garcia-Martin C., Boskovic J., Fernandez-Leiro R., Caceres J.F., Llorca O.;
RT   "Regulation of RUVBL1-RUVBL2 AAA-ATPases by the nonsense-mediated mRNA
RT   decay factor DHX34, as evidenced by Cryo-EM.";
RL   Elife 9:0-0(2020).
RN   [32]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-35; CYS-126; CYS-144; TYR-151; ASN-160;
RP   VAL-167; GLY-320; SER-465; ARG-546; SER-588; LYS-612; CYS-753; CYS-809;
RP   CYS-812; ILE-829; ASP-832; GLY-952; SER-969; LEU-1016; GLN-1029; SER-1072;
RP   HIS-1103; ARG-1275; PRO-1292; VAL-1332; PRO-1358; THR-1418; CYS-2171;
RP   SER-2258; LYS-2345; GLU-2730; SER-2889; ALA-2899; THR-3239 AND GLN-3583.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine protein kinase involved in both mRNA
CC       surveillance and genotoxic stress response pathways. Recognizes the
CC       substrate consensus sequence [ST]-Q. Plays a central role in nonsense-
CC       mediated decay (NMD) of mRNAs containing premature stop codons by
CC       phosphorylating UPF1/RENT1. Recruited by release factors to stalled
CC       ribosomes together with SMG8 and SMG9 (forming the SMG1C protein kinase
CC       complex), and UPF1 to form the transient SURF (SMG1-UPF1-eRF1-eRF3)
CC       complex. In EJC-dependent NMD, the SURF complex associates with the
CC       exon junction complex (EJC) through UPF2 and allows the formation of an
CC       UPF1-UPF2-UPF3 surveillance complex which is believed to activate NMD.
CC       Also acts as a genotoxic stress-activated protein kinase that displays
CC       some functional overlap with ATM. Can phosphorylate p53/TP53 and is
CC       required for optimal p53/TP53 activation after cellular exposure to
CC       genotoxic stress. Its depletion leads to spontaneous DNA damage and
CC       increased sensitivity to ionizing radiation (IR). May activate PRKCI
CC       but not PRKCZ. {ECO:0000269|PubMed:11331269,
CC       ECO:0000269|PubMed:11544179, ECO:0000269|PubMed:15175154,
CC       ECO:0000269|PubMed:16452507}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:19417104};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:19417104};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:11331269};
CC   -!- ACTIVITY REGULATION: Inhibited by caffeine, LY294002 and wortmannin.
CC       {ECO:0000269|PubMed:11331269, ECO:0000269|PubMed:11544179,
CC       ECO:0000269|PubMed:15175154}.
CC   -!- SUBUNIT: Component of the SMG1C complex composed of SMG1, SMG8 and
CC       SMG9; the recruitment of SMG8 to SMG1 N-terminus induces a large
CC       conformational change in the SMG1 C-terminal head domain containing the
CC       catalytic domain (PubMed:33205750). Component of the transient SURF
CC       (SMG1-UPF1-eRF1-eRF3) complex. Part of a complex composed of SMG1,
CC       DHX34 and UPF1; within the complex DHX34 acts as a scaffolding protein
CC       to facilitate SMG1 phosphorylation of UPF1 (PubMed:26841701). Interacts
CC       with PRKCI. Interacts with TELO2 and TTI1. Interacts with RUVBL1 and
CC       RUVBL2 (PubMed:33205750). Interacts with UPF2. Interacts with DHX34
CC       (via C-terminus); the interaction is RNA-independent (PubMed:25220460,
CC       PubMed:33205750). {ECO:0000269|PubMed:11544179,
CC       ECO:0000269|PubMed:12554878, ECO:0000269|PubMed:14636577,
CC       ECO:0000269|PubMed:16452507, ECO:0000269|PubMed:19417104,
CC       ECO:0000269|PubMed:20371770, ECO:0000269|PubMed:20427287,
CC       ECO:0000269|PubMed:20810650, ECO:0000269|PubMed:21245168,
CC       ECO:0000269|PubMed:25220460, ECO:0000269|PubMed:26841701,
CC       ECO:0000269|PubMed:33205750, ECO:0000269|PubMed:8524286}.
CC   -!- INTERACTION:
CC       Q96Q15; P11940: PABPC1; NbExp=2; IntAct=EBI-1049832, EBI-81531;
CC       Q96Q15; Q9HAU5: UPF2; NbExp=7; IntAct=EBI-1049832, EBI-372073;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15175154}. Cytoplasm
CC       {ECO:0000269|PubMed:15175154}. Note=Present in the chromatoid body.
CC       {ECO:0000250|UniProtKB:Q8BKX6}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q96Q15-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96Q15-2; Sequence=VSP_017748;
CC       Name=3;
CC         IsoId=Q96Q15-3; Sequence=VSP_017747;
CC       Name=4; Synonyms=BLIP;
CC         IsoId=Q96Q15-4; Sequence=VSP_017746;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest level in heart and
CC       skeletal muscle. Expressed in placenta, brain, lung and spleen, but not
CC       in liver. {ECO:0000269|PubMed:15175154, ECO:0000269|PubMed:8524286}.
CC   -!- PTM: Autophosphorylated. {ECO:0000305|PubMed:11331269,
CC       ECO:0000305|PubMed:11544179, ECO:0000305|PubMed:15175154}.
CC   -!- MISCELLANEOUS: This gene is located in a region of chromosome 16 that
CC       contains 2 segmental duplications. Other genes that are highly related
CC       to this exist, but they probably represent pseudogenes.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA86535.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF186377; AAK58892.1; -; mRNA.
DR   EMBL; AB061371; BAB70696.1; -; mRNA.
DR   EMBL; AY014957; AAK00511.1; -; mRNA.
DR   EMBL; AF395444; AAM73708.1; -; mRNA.
DR   EMBL; AC092287; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB007881; BAA24851.2; -; mRNA.
DR   EMBL; U32581; AAA86535.2; ALT_INIT; mRNA.
DR   CCDS; CCDS45430.1; -. [Q96Q15-1]
DR   PIR; JC6084; JC6084.
DR   RefSeq; NP_055907.3; NM_015092.4. [Q96Q15-1]
DR   PDB; 6L53; EM; 3.63 A; A=1-3661.
DR   PDB; 6L54; EM; 3.43 A; A=1-3661.
DR   PDB; 6SYT; EM; 3.45 A; A=311-3661.
DR   PDB; 6Z3R; EM; 2.97 A; A=259-3661.
DR   PDB; 7PW4; EM; 3.27 A; A=311-3661.
DR   PDB; 7PW5; EM; 3.40 A; A=311-3661.
DR   PDB; 7PW6; EM; 3.05 A; A=766-3661.
DR   PDB; 7PW7; EM; 3.59 A; A=311-3661.
DR   PDB; 7PW8; EM; 2.82 A; A=311-3661.
DR   PDB; 7PW9; EM; 3.12 A; A=311-3661.
DR   PDBsum; 6L53; -.
DR   PDBsum; 6L54; -.
DR   PDBsum; 6SYT; -.
DR   PDBsum; 6Z3R; -.
DR   PDBsum; 7PW4; -.
DR   PDBsum; 7PW5; -.
DR   PDBsum; 7PW6; -.
DR   PDBsum; 7PW7; -.
DR   PDBsum; 7PW8; -.
DR   PDBsum; 7PW9; -.
DR   SMR; Q96Q15; -.
DR   BioGRID; 116687; 82.
DR   CORUM; Q96Q15; -.
DR   IntAct; Q96Q15; 39.
DR   MINT; Q96Q15; -.
DR   STRING; 9606.ENSP00000402515; -.
DR   BindingDB; Q96Q15; -.
DR   ChEMBL; CHEMBL1795195; -.
DR   GuidetoPHARMACOLOGY; 2201; -.
DR   iPTMnet; Q96Q15; -.
DR   MetOSite; Q96Q15; -.
DR   PhosphoSitePlus; Q96Q15; -.
DR   BioMuta; SMG1; -.
DR   DMDM; 322510104; -.
DR   EPD; Q96Q15; -.
DR   jPOST; Q96Q15; -.
DR   MassIVE; Q96Q15; -.
DR   MaxQB; Q96Q15; -.
DR   PaxDb; Q96Q15; -.
DR   PeptideAtlas; Q96Q15; -.
DR   PRIDE; Q96Q15; -.
DR   ProteomicsDB; 77810; -. [Q96Q15-1]
DR   ProteomicsDB; 77811; -. [Q96Q15-2]
DR   ProteomicsDB; 77812; -. [Q96Q15-3]
DR   ProteomicsDB; 77813; -. [Q96Q15-4]
DR   Antibodypedia; 6280; 217 antibodies from 16 providers.
DR   DNASU; 23049; -.
DR   Ensembl; ENST00000446231.7; ENSP00000402515.3; ENSG00000157106.18. [Q96Q15-1]
DR   GeneID; 23049; -.
DR   KEGG; hsa:23049; -.
DR   MANE-Select; ENST00000446231.7; ENSP00000402515.3; NM_015092.5; NP_055907.3.
DR   UCSC; uc002dfm.4; human. [Q96Q15-1]
DR   CTD; 23049; -.
DR   DisGeNET; 23049; -.
DR   GeneCards; SMG1; -.
DR   HGNC; HGNC:30045; SMG1.
DR   HPA; ENSG00000157106; Low tissue specificity.
DR   MIM; 607032; gene.
DR   neXtProt; NX_Q96Q15; -.
DR   OpenTargets; ENSG00000157106; -.
DR   PharmGKB; PA164725852; -.
DR   VEuPathDB; HostDB:ENSG00000157106; -.
DR   eggNOG; KOG0891; Eukaryota.
DR   GeneTree; ENSGT00940000154776; -.
DR   InParanoid; Q96Q15; -.
DR   OMA; EAIIMRH; -.
DR   OrthoDB; 26975at2759; -.
DR   PhylomeDB; Q96Q15; -.
DR   TreeFam; TF352560; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; Q96Q15; -.
DR   Reactome; R-HSA-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   SignaLink; Q96Q15; -.
DR   SIGNOR; Q96Q15; -.
DR   BioGRID-ORCS; 23049; 646 hits in 1124 CRISPR screens.
DR   ChiTaRS; SMG1; human.
DR   GeneWiki; SMG1_(gene); -.
DR   GenomeRNAi; 23049; -.
DR   Pharos; Q96Q15; Tchem.
DR   PRO; PR:Q96Q15; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q96Q15; protein.
DR   Bgee; ENSG00000157106; Expressed in upper leg skin and 192 other tissues.
DR   ExpressionAtlas; Q96Q15; baseline and differential.
DR   Genevisible; Q96Q15; HS.
DR   GO; GO:0033391; C:chromatoid body; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031931; C:TORC1 complex; IBA:GO_Central.
DR   GO; GO:0031932; C:TORC2 complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; TAS:UniProtKB.
DR   GO; GO:0004697; F:protein kinase C activity; EXP:Reactome.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0042162; F:telomeric DNA binding; IDA:BHF-UCL.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0006406; P:mRNA export from nucleus; TAS:UniProtKB.
DR   GO; GO:0016242; P:negative regulation of macroautophagy; IBA:GO_Central.
DR   GO; GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IDA:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0046854; P:phosphatidylinositol phosphate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:2001020; P:regulation of response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0032204; P:regulation of telomere maintenance; IMP:BHF-UCL.
DR   GO; GO:0031929; P:TOR signaling; IBA:GO_Central.
DR   CDD; cd05170; PIKKc_SMG1; 1.
DR   Gene3D; 1.10.1070.11; -; 1.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR003152; FATC_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   InterPro; IPR036940; PI3/4_kinase_cat_sf.
DR   InterPro; IPR018936; PI3/4_kinase_CS.
DR   InterPro; IPR014009; PIK_FAT.
DR   InterPro; IPR031559; SMG1.
DR   InterPro; IPR035175; SMG1_N.
DR   InterPro; IPR039414; SMG1_PIKKc.
DR   Pfam; PF02260; FATC; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   Pfam; PF15785; SMG1; 1.
DR   Pfam; PF17229; SMG1_N; 1.
DR   SMART; SM01343; FATC; 1.
DR   SMART; SM00146; PI3Kc; 1.
DR   SUPFAM; SSF48371; SSF48371; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51189; FAT; 1.
DR   PROSITE; PS51190; FATC; 1.
DR   PROSITE; PS00916; PI3_4_KINASE_2; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Cytoplasm;
KW   DNA damage; DNA repair; Kinase; Manganese; Metal-binding;
KW   Nonsense-mediated mRNA decay; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..3661
FT                   /note="Serine/threonine-protein kinase SMG1"
FT                   /id="PRO_0000229791"
FT   DOMAIN          1283..1866
FT                   /note="FAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00534"
FT   REPEAT          1817..1852
FT                   /note="HEAT"
FT   DOMAIN          2124..2463
FT                   /note="PI3K/PI4K catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   DOMAIN          3629..3661
FT                   /note="FATC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00534,
FT                   ECO:0000255|PROSITE-ProRule:PRU00535"
FT   REGION          1..1977
FT                   /note="Interaction with SMG8 and SMG9"
FT                   /evidence="ECO:0000269|PubMed:21245168"
FT   REGION          1..101
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          116..144
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1154..1175
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1898..1919
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2130..2136
FT                   /note="G-loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          2332..2340
FT                   /note="Catalytic loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          2352..2376
FT                   /note="Activation loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          3568..3591
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        25..67
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        68..82
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        87..101
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        128..142
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        3568..3583
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         173
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         3550
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:17525332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         3556
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17525332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         3570
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         3573
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         3577
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BKX6"
FT   VAR_SEQ         1..1269
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:9566925"
FT                   /id="VSP_017746"
FT   VAR_SEQ         1..630
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11331269"
FT                   /id="VSP_017747"
FT   VAR_SEQ         1..140
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15175154"
FT                   /id="VSP_017748"
FT   VARIANT         35
FT                   /note="A -> T (in dbSNP:rs12051350)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041623"
FT   VARIANT         126
FT                   /note="R -> C (in dbSNP:rs752796432)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041624"
FT   VARIANT         144
FT                   /note="S -> C (in dbSNP:rs766737607)"
FT                   /evidence="ECO:0000269|PubMed:15175154,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041625"
FT   VARIANT         151
FT                   /note="N -> Y (in dbSNP:rs750788715)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041626"
FT   VARIANT         160
FT                   /note="D -> N"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041627"
FT   VARIANT         167
FT                   /note="A -> V (in dbSNP:rs1382468496)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041628"
FT   VARIANT         320
FT                   /note="D -> G"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041629"
FT   VARIANT         465
FT                   /note="G -> S (in dbSNP:rs200419100)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041630"
FT   VARIANT         546
FT                   /note="H -> R (in dbSNP:rs376234691)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041631"
FT   VARIANT         588
FT                   /note="A -> S (in dbSNP:rs750840136)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041632"
FT   VARIANT         612
FT                   /note="I -> K (in dbSNP:rs17842615)"
FT                   /evidence="ECO:0000269|PubMed:15175154,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041633"
FT   VARIANT         753
FT                   /note="S -> C (in dbSNP:rs569679854)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041634"
FT   VARIANT         809
FT                   /note="S -> C (in dbSNP:rs919788709)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041635"
FT   VARIANT         812
FT                   /note="R -> C (in dbSNP:rs1233400465)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041636"
FT   VARIANT         829
FT                   /note="V -> I"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041637"
FT   VARIANT         832
FT                   /note="N -> D (in dbSNP:rs80176913)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041638"
FT   VARIANT         952
FT                   /note="A -> G (in dbSNP:rs555078480)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041639"
FT   VARIANT         969
FT                   /note="N -> S (in dbSNP:rs1412788971)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041640"
FT   VARIANT         1016
FT                   /note="F -> L (in dbSNP:rs1394431566)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041641"
FT   VARIANT         1029
FT                   /note="R -> Q"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041642"
FT   VARIANT         1072
FT                   /note="T -> S (in dbSNP:rs45516593)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041643"
FT   VARIANT         1103
FT                   /note="N -> H (in dbSNP:rs563883658)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041644"
FT   VARIANT         1275
FT                   /note="P -> R"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041645"
FT   VARIANT         1292
FT                   /note="Q -> P (in dbSNP:rs375411122)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041646"
FT   VARIANT         1332
FT                   /note="I -> V (in dbSNP:rs949474935)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041647"
FT   VARIANT         1358
FT                   /note="S -> P"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041648"
FT   VARIANT         1418
FT                   /note="R -> T (in dbSNP:rs17731779)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041649"
FT   VARIANT         2171
FT                   /note="S -> C (in a breast pleomorphic lobular carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041650"
FT   VARIANT         2258
FT                   /note="G -> S (in dbSNP:rs35572280)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041651"
FT   VARIANT         2345
FT                   /note="M -> K (in dbSNP:rs56276814)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041652"
FT   VARIANT         2730
FT                   /note="Q -> E (in dbSNP:rs34960798)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041653"
FT   VARIANT         2889
FT                   /note="G -> S (in dbSNP:rs35952340)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041654"
FT   VARIANT         2899
FT                   /note="P -> A (in dbSNP:rs55782217)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041655"
FT   VARIANT         3239
FT                   /note="I -> T (in a breast infiltrating ductal carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041656"
FT   VARIANT         3583
FT                   /note="K -> Q (in a breast infiltrating ductal carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041657"
FT   MUTAGEN         2335
FT                   /note="D->A: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:11331269,
FT                   ECO:0000269|PubMed:11544179, ECO:0000269|PubMed:15175154"
FT   CONFLICT        14
FT                   /note="G -> GGGGG (in Ref. 2; BAB70696)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        20
FT                   /note="K -> N (in Ref. 2; BAB70696)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        22
FT                   /note="P -> S (in Ref. 2; BAB70696)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        40
FT                   /note="D -> G (in Ref. 2; BAB70696)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        686
FT                   /note="S -> A (in Ref. 2; BAB70696)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        743
FT                   /note="K -> R (in Ref. 2; BAB70696)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1193
FT                   /note="C -> F (in Ref. 2; BAB70696)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2009
FT                   /note="K -> R (in Ref. 2; BAB70696)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2077
FT                   /note="S -> N (in Ref. 1; AAK58892)"
FT                   /evidence="ECO:0000305"
FT   HELIX           38..42
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           62..69
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           70..73
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           81..88
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   TURN            94..96
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           97..102
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           103..105
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   STRAND          110..113
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           114..117
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           124..141
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   STRAND          143..148
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           151..153
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           154..162
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   TURN            163..167
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           171..174
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           178..181
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           189..198
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   TURN            199..201
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           202..204
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           211..222
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           230..245
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           261..274
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           281..292
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           297..306
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           307..309
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           314..321
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           322..324
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           326..330
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           336..346
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           356..373
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           380..387
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           389..394
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           395..411
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           421..424
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           429..443
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            445..447
FT                   /evidence="ECO:0007829|PDB:7PW9"
FT   HELIX           450..466
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          469..471
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           475..486
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          490..492
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           494..510
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           517..523
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           529..532
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           533..535
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           539..552
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           558..582
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           590..592
FT                   /evidence="ECO:0007829|PDB:7PW4"
FT   HELIX           595..597
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           598..600
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           604..622
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           625..630
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   STRAND          634..636
FT                   /evidence="ECO:0007829|PDB:7PW9"
FT   HELIX           638..644
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           647..650
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           653..656
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           658..673
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           674..678
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            679..681
FT                   /evidence="ECO:0007829|PDB:7PW9"
FT   TURN            700..705
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           706..718
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           725..741
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           746..753
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           755..766
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          768..771
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           773..785
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           792..805
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          807..810
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           811..821
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           826..829
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          831..833
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           836..850
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           859..870
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           882..889
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            890..895
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           903..905
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           909..926
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            927..929
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           936..955
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            962..964
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           970..998
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          1002..1005
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1010..1018
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1020..1040
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1044..1057
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1068..1082
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1086..1096
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1107..1114
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            1115..1117
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           1118..1133
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          1134..1136
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           1144..1150
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1180..1196
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1200..1215
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            1216..1218
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           1228..1239
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1242..1249
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          1251..1255
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1282..1304
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          1315..1317
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1318..1331
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1333..1340
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1348..1366
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1371..1373
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1379..1382
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1391..1406
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1407..1409
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1418..1433
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            1434..1436
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1438..1449
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1459..1466
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1467..1479
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           1480..1494
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1497..1511
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          1514..1516
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1518..1534
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1536..1550
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1560..1569
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1587..1590
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   STRAND          1591..1593
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1596..1611
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1616..1636
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1640..1648
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           1651..1659
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1668..1677
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1686..1695
FT                   /evidence="ECO:0007829|PDB:6SYT"
FT   HELIX           1708..1719
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1720..1725
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           1729..1740
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1742..1756
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1782..1798
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          1801..1803
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1804..1813
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            1818..1821
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1823..1828
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1829..1831
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1836..1849
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1853..1855
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1857..1864
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1925..1938
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          1939..1941
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           1942..1957
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1963..1977
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           1980..1992
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           2011..2023
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           2036..2044
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           2047..2054
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           2069..2082
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2085..2087
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   STRAND          2090..2092
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            2097..2101
FT                   /evidence="ECO:0007829|PDB:7PW9"
FT   STRAND          2120..2124
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2126..2130
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2132..2136
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2138..2144
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2149..2157
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           2161..2175
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            2176..2179
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           2180..2182
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2195..2197
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2199..2201
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2203..2206
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2212..2214
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           2215..2231
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           2249..2262
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2272..2274
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           2277..2290
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           2295..2303
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           2307..2331
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2340..2343
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            2345..2347
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2350..2352
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   TURN            2356..2360
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           2361..2363
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2364..2367
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           2377..2381
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2384..2386
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   STRAND          2388..2390
FT                   /evidence="ECO:0007829|PDB:6Z3R"
FT   HELIX           2391..2405
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           2407..2418
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          2422..2424
FT                   /evidence="ECO:0007829|PDB:6L54"
FT   HELIX           3608..3620
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   STRAND          3627..3629
FT                   /evidence="ECO:0007829|PDB:7PW6"
FT   HELIX           3633..3645
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           3647..3651
FT                   /evidence="ECO:0007829|PDB:7PW8"
FT   HELIX           3655..3657
FT                   /evidence="ECO:0007829|PDB:7PW8"
SQ   SEQUENCE   3661 AA;  410501 MW;  216A55F3121F5829 CRC64;
     MSRRAPGSRL SSGGGGGGTK YPRSWNDWQP RTDSASADPD NLKYSSSRDR GGSSSYGLQP
     SNSAVVSRQR HDDTRVHADI QNDEKGGYSV NGGSGENTYG RKSLGQELRV NNVTSPEFTS
     VQHGSRALAT KDMRKSQERS MSYSDESRLS NLLRRITRED DRDRRLATVK QLKEFIQQPE
     NKLVLVKQLD NILAAVHDVL NESSKLLQEL RQEGACCLGL LCASLSYEAE KIFKWIFSKF
     SSSAKDEVKL LYLCATYKAL ETVGEKKAFS SVMQLVMTSL QSILENVDTP ELLCKCVKCI
     LLVARCYPHI FSTNFRDTVD ILVGWHIDHT QKPSLTQQVS GWLQSLEPFW VADLAFSTTL
     LGQFLEDMEA YAEDLSHVAS GESVDEDVPP PSVSLPKLAA LLRVFSTVVR SIGERFSPIR
     GPPITEAYVT DVLYRVMRCV TAANQVFFSE AVLTAANECV GVLLGSLDPS MTIHCDMVIT
     YGLDQLENCQ TCGTDYIISV LNLLTLIVEQ INTKLPSSFV EKLFIPSSKL LFLRYHKEKE
     VVAVAHAVYQ AVLSLKNIPV LETAYKLILG EMTCALNNLL HSLQLPEACS EIKHEAFKNH
     VFNVDNAKFV VIFDLSALTT IGNAKNSLIG MWALSPTVFA LLSKNLMIVH SDLAVHFPAI
     QYAVLYTLYS HCTRHDHFIS SSLSSSSPSL FDGAVISTVT TATKKHFSII LNLLGILLKK
     DNLNQDTRKL LMTWALEAAV LMKKSETYAP LFSLPSFHKF CKGLLANTLV EDVNICLQAC
     SSLHALSSSL PDDLLQRCVD VCRVQLVHSG TRIRQAFGKL LKSIPLDVVL SNNNHTEIQE
     ISLALRSHMS KAPSNTFHPQ DFSDVISFIL YGNSHRTGKD NWLERLFYSC QRLDKRDQST
     IPRNLLKTDA VLWQWAIWEA AQFTVLSKLR TPLGRAQDTF QTIEGIIRSL AAHTLNPDQD
     VSQWTTADND EGHGNNQLRL VLLLQYLENL EKLMYNAYEG CANALTSPPK VIRTFFYTNR
     QTCQDWLTRI RLSIMRVGLL AGQPAVTVRH GFDLLTEMKT TSLSQGNELE VTIMMVVEAL
     CELHCPEAIQ GIAVWSSSIV GKNLLWINSV AQQAEGRFEK ASVEYQEHLC AMTGVDCCIS
     SFDKSVLTLA NAGRNSASPK HSLNGESRKT VLSKPTDSSP EVINYLGNKA CECYISIADW
     AAVQEWQNAI HDLKKSTSST SLNLKADFNY IKSLSSFESG KFVECTEQLE LLPGENINLL
     AGGSKEKIDM KKLLPNMLSP DPRELQKSIE VQLLRSSVCL ATALNPIEQD QKWQSITENV
     VKYLKQTSRI AIGPLRLSTL TVSQSLPVLS TLQLYCSSAL ENTVSNRLST EDCLIPLFSE
     ALRSCKQHDV RPWMQALRYT MYQNQLLEKI KEQTVPIRSH LMELGLTAAK FARKRGNVSL
     ATRLLAQCSE VQLGKTTTAQ DLVQHFKKLS TQGQVDEKWG PELDIEKTKL LYTAGQSTHA
     MEMLSSCAIS FCKSVKAEYA VAKSILTLAK WIQAEWKEIS GQLKQVYRAQ HQQNFTGLST
     LSKNILTLIE LPSVNTMEEE YPRIESESTV HIGVGEPDFI LGQLYHLSSV QAPEVAKSWA
     ALASWAYRWG RKVVDNASQG EGVRLLPREK SEVQNLLPDT ITEEEKERIY GILGQAVCRP
     AGIQDEDITL QITESEDNEE DDMVDVIWRQ LISSCPWLSE LDESATEGVI KVWRKVVDRI
     FSLYKLSCSA YFTFLKLNAG QIPLDEDDPR LHLSHRVEQS TDDMIVMATL RLLRLLVKHA
     GELRQYLEHG LETTPTAPWR GIIPQLFSRL NHPEVYVRQS ICNLLCRVAQ DSPHLILYPA
     IVGTISLSSE SQASGNKFST AIPTLLGNIQ GEELLVSECE GGSPPASQDS NKDEPKSGLN
     EDQAMMQDCY SKIVDKLSSA NPTMVLQVQM LVAELRRVTV LWDELWLGVL LQQHMYVLRR
     IQQLEDEVKR VQNNNTLRKE EKIAIMREKH TALMKPIVFA LEHVRSITAA PAETPHEKWF
     QDNYGDAIEN ALEKLKTPLN PAKPGSSWIP FKEIMLSLQQ RAQKRASYIL RLEEISPWLA
     AMTNTEIALP GEVSARDTVT IHSVGGTITI LPTKTKPKKL LFLGSDGKSY PYLFKGLEDL
     HLDERIMQFL SIVNTMFATI NRQETPRFHA RHYSVTPLGT RSGLIQWVDG ATPLFGLYKR
     WQQREAALQA QKAQDSYQTP QNPGIVPRPS ELYYSKIGPA LKTVGLSLDV SRRDWPLHVM
     KAVLEELMEA TPPNLLAKEL WSSCTTPDEW WRVTQSYARS TAVMSMVGYI IGLGDRHLDN
     VLIDMTTGEV VHIDYNVCFE KGKSLRVPEK VPFRMTQNIE TALGVTGVEG VFRLSCEQVL
     HIMRRGRETL LTLLEAFVYD PLVDWTAGGE AGFAGAVYGG GGQQAESKQS KREMEREITR
     SLFSSRVAEI KVNWFKNRDE MLVVLPKLDG SLDEYLSLQE QLTDVEKLQG KLLEEIEFLE
     GAEGVDHPSH TLQHRYSEHT QLQTQQRAVQ EAIQVKLNEF EQWITHYQAA FNNLEATQLA
     SLLQEISTQM DLGPPSYVPA TAFLQNAGQA HLISQCEQLE GEVGALLQQR RSVLRGCLEQ
     LHHYATVALQ YPKAIFQKHR IEQWKTWMEE LICNTTVERC QELYRKYEMQ YAPQPPPTVC
     QFITATEMTL QRYAADINSR LIRQVERLKQ EAVTVPVCED QLKEIERCIK VFLHENGEEG
     SLSLASVIIS ALCTLTRRNL MMEGAASSAG EQLVDLTSRD GAWFLEELCS MSGNVTCLVQ
     LLKQCHLVPQ DLDIPNPMEA SETVHLANGV YTSLQELNSN FRQIIFPEAL RCLMKGEYTL
     ESMLHELDGL IEQTTDGVPL QTLVESLQAY LRNAAMGLEE ETHAHYIDVA RLLHAQYGEL
     IQPRNGSVDE TPKMSAGQML LVAFDGMFAQ VETAFSLLVE KLNKMEIPIA WRKIDIIREA
     RSTQVNFFDD DNHRQVLEEI FFLKRLQTIK EFFRLCGTFS KTLSGSSSLE DQNTVNGPVQ
     IVNVKTLFRN SCFSEDQMAK PIKAFTADFV RQLLIGLPNQ ALGLTLCSFI SALGVDIIAQ
     VEAKDFGAES KVSVDDLCKK AVEHNIQIGK FSQLVMNRAT VLASSYDTAW KKHDLVRRLE
     TSISSCKTSL QRVQLHIAMF QWQHEDLLIN RPQAMSVTPP PRSAILTSMK KKLHTLSQIE
     TSIATVQEKL AALESSIEQR LKWAGGANPA LAPVLQDFEA TIAERRNLVL KESQRASQVT
     FLCSNIIHFE SLRTRTAEAL NLDAALFELI KRCQQMCSFA SQFNSSVSEL ELRLLQRVDT
     GLEHPIGSSE WLLSAHKQLT QDMSTQRAIQ TEKEQQIETV CETIQNLVDN IKTVLTGHNR
     QLGDVKHLLK AMAKDEEAAL ADGEDVPYEN SVRQFLGEYK SWQDNIQTVL FTLVQAMGQV
     RSQEHVEMLQ EITPTLKELK TQSQSIYNNL VSFASPLVTD ATNECSSPTS SATYQPSFAA
     AVRSNTGQKT QPDVMSQNAR KLIQKNLATS ADTPPSTVPG TGKSVACSPK KAVRDPKTGK
     AVQERNSYAV SVWKRVKAKL EGRDVDPNRR MSVAEQVDYV IKEATNLDNL AQLYEGWTAW
     V
//
